Patent 7264956 was granted and assigned to Givaudan on September, 2007 by the United States Patent and Trademark Office.
Enzymes mediating in the release of compounds characteristic of human malodour and in particular axillary malodour, and compounds that inhibit said enzymes having the general formula (I)